Literature DB >> 10437642

Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers.

D Mantle1, G Falkous, D Walker.   

Abstract

We have compared (using the same series of experimental samples) the levels of activity of a comprehensive range of cytoplasmic, lysosomal and matrix protease types, together with the levels of free radical-induced protein damage (determined as protein carbonyl derivative) in synovial fluid from rheumatoid (RA) and osteoarthritis (OA) cases. Many protease types showed significantly increased activity (typically by a factor of 2-3-fold) in RA compared to OA cases. Protease activity levels (including those enzyme types putatively involved in the immune response, such as dipeptidyl aminopeptidase IV) in plasma were not significantly different in RA and control cases. The level of free radical induced damage to synovial fluid proteins was approximately 2-fold higher in RA compared to OA, although there was no significant difference in total antioxidant status in synovial fluid or plasma between RA, OA or control cases. We conclude from the above that activation of proteolytic enzymes and free radicals (occurring specifically within synovial tissues) are likely to be of equal potential importance as protein damaging agents in the pathogenesis of RA, and the development of novel therapeutic strategies for the latter disorder should include both protease inhibitory and free radical scavenging elements. In addition, the protease inhibitory element should be designed to inhibit the action of a broad range of enzymic mechanistic types (cysteine, serine, metallo proteinases and peptidases).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10437642     DOI: 10.1016/s0009-8981(99)00055-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection.

Authors:  Omidreza Firuzi; Premysl Mladenka; Valeria Riccieri; Antonio Spadaro; Rita Petrucci; Giancarlo Marrosu; Luciano Saso
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis.

Authors:  Farshid Yeganeh; Seyed Mohammad Javad Mousavi; Saeed Hosseinzadeh-Sarband; Arman Ahmadzadeh; Hooman Bahrami-Motlagh; Mostafa Haji Molla Hoseini; Mandana Sattari; Mohammad Reza Sohrabi; Ramin Pouriran; Pooneh Dehghan
Journal:  Clin Rheumatol       Date:  2018-08-22       Impact factor: 2.980

Review 3.  Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.

Authors:  Roger Yazbeck; Simone E Jaenisch; Catherine A Abbott
Journal:  Protoplasma       Date:  2017-06-16       Impact factor: 3.356

4.  Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.

Authors:  Hasan Ulusoy; Ayhan Kamanli; Necip Ilhan; Omer Kuru; Sule Arslan; Gokhan Alkan; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

5.  Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis.

Authors:  Suhana Datta; Sunanda Kundu; Parasar Ghosh; Soumita De; Alakendu Ghosh; Mitali Chatterjee
Journal:  Clin Rheumatol       Date:  2014-04-10       Impact factor: 2.980

6.  Effect of allopurinol and vitamin e on rat model of rheumatoid arthritis.

Authors:  Mohamad Alorainy
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

Review 7.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

8.  Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients.

Authors:  Omidreza Firuzi; Antonio Spadaro; Chiara Spadaro; Valeria Riccieri; Rita Petrucci; Giancarlo Marrosu; Luciano Saso
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity.

Authors:  Rachel Morgan; Judith Endres; Nilofar Behbahani-Nejad; Kristine Phillips; Jeffrey H Ruth; Sean C Friday; Gautam Edhayan; Thomas Lanigan; Andrew Urquhart; Kevin C Chung; David A Fox
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

10.  Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis.

Authors:  Riva Brik; Irit Rosen; Dana Savulescu; Iris Borovoi; Moshe Gavish; Rafael Nagler
Journal:  Mol Med       Date:  2009-12-28       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.